ONCOLYS BIOPHARMA INCOO

ONCOLYS BIOPHARMA INC

623JPYD
−37−5,61%
Última atualização em 21 de fev., 06:25 GMT
JPY
Sem negociações
Veja nos super gráficos
Voltar

EBIT de ONCOLYS BIOPHARMA INC.

Dados anuais
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
TTM
‪‪−2,00 B‬‬
‪‪−1,50 B‬‬
‪‪−1,00 B‬‬
‪‪−500,00 M‬‬
‪0,00‬
Período
Valor
Variação
Variação %
TTM
‪‪−1,68 B‬‬
‪0,00‬
‪0,00‬%
2024
‪‪−1,68 B‬‬
+‪‪248,58 M‬‬
+‪12,88‬%
2023
‪‪−1,93 B‬‬
‪‪−725,48 M‬‬
‪−60,23‬%
2022
‪‪−1,20 B‬‬
+‪‪250,05 M‬‬
+‪17,19‬%
2021
‪‪−1,45 B‬‬
+‪‪255,78 M‬‬
+‪14,95‬%
2020
‪‪−1,71 B‬‬
‪‪−1,19 B‬‬
‪−228,10‬%
2019
2018
2017
2016
2015
2014
2013
2012
2011
Dados trimestrais
Q2 '17
Q3 '17
Q4 '17
Q1 '18
Q2 '18
Q3 '18
Q4 '18
Q1 '19
Q2 '19
Q3 '19
Q4 '19
Q1 '20
Q2 '20
Q3 '20
Q4 '20
Q1 '21
Q2 '21
Q3 '21
Q4 '21
Q1 '22
Q2 '22
Q3 '22
Q4 '22
Q1 '23
Q2 '23
Q3 '23
Q4 '23
Q1 '24
Q2 '24
Q3 '24
Q4 '24
‪‪−640,00 M‬‬
‪‪−480,00 M‬‬
‪‪−320,00 M‬‬
‪‪−160,00 M‬‬
‪0,00‬
Período
Valor
Variação
Variação %
Q4 '24
‪‪−451,26 M‬‬
‪‪−14,50 M‬‬
‪−3,32‬%
Q3 '24
‪‪−436,77 M‬‬
‪‪−22,27 M‬‬
‪−5,37‬%
Q2 '24
‪‪−414,50 M‬‬
‪‪−35,63 M‬‬
‪−9,40‬%
Q1 '24
‪‪−378,87 M‬‬
+‪‪240,08 M‬‬
+‪38,79‬%
Q4 '23
‪‪−618,95 M‬‬
‪‪−208,90 M‬‬
‪−50,94‬%
Q3 '23
‪‪−410,05 M‬‬
+‪‪165,36 M‬‬
+‪28,74‬%
Q2 '23
‪‪−575,41 M‬‬
‪‪−249,83 M‬‬
‪−76,74‬%
Q1 '23
‪‪−325,58 M‬‬
‪‪−58,45 M‬‬
‪−21,88‬%
Q4 '22
Q3 '22
Q2 '22
Q1 '22
Q4 '21
Q3 '21
Q2 '21
Q1 '21
Q4 '20
Q3 '20
Q2 '20
Q1 '20
Q4 '19
Q3 '19
Q2 '19
Q1 '19
Q4 '18
Q3 '18
Q2 '18
Q1 '18
Q4 '17
Q3 '17
Q2 '17